MetaADEDB 2.0 @ LMMD
Prilocaine
(MVFGUOIZUNYYSO-UHFFFAOYSA-N)
Structure
SMILES
CCCNC(C(=O)Nc1ccccc1C)C
Type(s)
Approved
ATC code(s)
N01BB04; N01BB54
Molecular Formula:
C13H20N2O
Molecular Weight:
220.311
Log P:
2.7855
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
2
TPSA:
41.13
CAS Number(s):
721-50-6
Synonym(s)
1.
Prilocaine
2.
Propitocaine
3.
Citanest
4.
Citanest Octapressin
5.
Prilocaine Hydrochloride
6.
Xylonest
External Link(s)
MeSHD011318
PubChem Compound4906
BindingDB50225477
ChEBI8404
CHEMBLCHEMBL1194
DrugBankDB00750
DrugCentral2265
IUPHAR/BPS Guide to PHARMACOLOGY7276
KEGGcpd:C07531
dr:D00553
Therapeutic Target DatabaseD06LYG
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Nerve injuryFAERS: 14SIDER
US FAERS
2AgeusiaFAERS: 2US FAERS
3AngioedemaFAERS: 2
Canada Vigilance: 1		15681715CTD
Canada Vigilance
US FAERS
4DizzinessFAERS: 2
Canada Vigilance: 1		Canada Vigilance
SIDER
US FAERS
5DysgeusiaFAERS: 2US FAERS
6HypokinesiaFAERS: 2US FAERS
7NauseaFAERS: 2
Canada Vigilance: 1		Canada Vigilance
SIDER
US FAERS
8NystagmusFAERS: 2US FAERS
9Post procedural complicationFAERS: 2US FAERS
10AllodyniaFAERS: 1US FAERS
11BronchospasmFAERS: 1SIDER
US FAERS
12Cardiac ArrestFAERS: 1SIDER
US FAERS
13Oral painFAERS: 1US FAERS
14TremorFAERS: 1SIDER
US FAERS
15TrismusFAERS: 1US FAERS
16AcidosisSIDER
17Anaphylactic shockSIDER
18Anaphylactoid ReactionSIDER
19Anemia5313657CTD
20AnemicSIDER
21AnxietySIDER
22ArachnoiditisSIDER
23AstheniaSIDER
24Blood pH decreasedSIDER
25Bradycardia10902449CTD
SIDER
26Brain HypoxiaSIDER
27Carotid pulseSIDER
28Circumoral paresthesiaSIDER
29CyanosisCanada Vigilance: 1Canada Vigilance
SIDER
30Depressed Level of ConsciousnessSIDER
31DiplopiaSIDER
32DisorientationCanada Vigilance: 1Canada Vigilance
SIDER
33DrowsinessSIDER
34DysarthriaSIDER
35Euphoric moodSIDER
36ExtravasationSIDER
37Feeling abnormalSIDER
38Headache5090228CTD
39Hearing Loss9522143CTD
40HyperacusisSIDER
41HypersensitivitySIDER
42Hypotension5090228
5313657
10902449		CTD
SIDER
43HypoxemiaSIDER
44HypoxiaSIDER
45Intraoperative Complications10902449
16001319		CTD
46LightheadednessSIDER
47Low pHSIDER
48Methemoglobinemia3537620
5313657		CTD
49Myoclonus19499876CTD
50Nerve Degeneration19587614CTD
51NervousnessSIDER
52Neurologic reactionSIDER
53NeuropathySIDER
54Numbness of tongueSIDER
55NumbnessSIDER
56Pain843977
7793189
11040906		CTD
SIDER
57Paresis843977CTD
58Paresthesia lipsSIDER
59Paresthesia9587732CTD
60Penile Diseases15681715CTD
61Postoperative Complications20338955CTD
62Pulmonary function test decreasedSIDER
63Respiratory DepressionSIDER
64Respiratory FailureSIDER
65Respiratory InsufficiencySIDER
66Respiratory arrestSIDER
67Seizures6774348
20122591		CTD
68ShockSIDER
69SomnolenceSIDER
70Spasm16001319CTD
71SweatingSIDER
72SwellingSIDER
73SyncopeCanada Vigilance: 1Canada Vigilance
SIDER
74Tachycardia9587732CTD
75TensionSIDER
76TinnitusSIDER
77TraumaSIDER
78Urinary Retention20338955CTD
79UrticariaSIDER
80Vocal Cord Paralysis17543491CTD
81VomitingSIDER
82apprehensionSIDER
83nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.